XML 22 R4.htm IDEA: XBRL DOCUMENT v3.22.0.1
Consolidated Statements of Changes in Shareholders' Equity - USD ($)
$ in Thousands
Share capital.
Contributed surplus
Accumulated other comprehensive income (loss)
Deficit
Total
Balance at the beginning at Dec. 31, 2019 $ 100,298 $ 15,076 $ 7,369 $ (108,372) $ 14,371
Balance at the beginning (in shares) at Dec. 31, 2019 11,852,749        
Net loss for the year       (21,622) (21,622)
Cumulative translation adjustment - net of tax of nil $ 7,040 94 (2,802)   4,332
Exercise of share options $ 3,025 (1,199)     1,826
Exercise of share options (in shares) 235,131        
Exercise of warrants $ 22,070 (5,739)     16,331
Exercise of warrants (shares) 1,556,154        
Share-based compensation (note 13)   3,018     3,018
Issuance of units from offering (note 12) $ 79,094       79,094
Issuance of units from offering (in shares) 6,564,914        
Balance at the end at Dec. 31, 2020 $ 211,527 11,250 4,567 (129,994) 97,350
Balance at the end (in shares) at Dec. 31, 2020 20,208,948        
Net loss for the year       (30,699) (30,699)
Cumulative translation adjustment - net of tax of nil $ 168 (18) 179   329
Exercise of share options $ 992 (397)     595
Exercise of share options (in shares) 79,208        
Exercise of warrants $ 6,836 (998)     5,838
Exercise of warrants (shares) 485,161        
Vesting of RSUs $ 56 (56)      
Vesting of RSUs (in shares) 2,900        
Share-based compensation (note 13)   7,205     7,205
Balance at the end at Dec. 31, 2021 $ 219,579 $ 16,986 $ 4,746 $ (160,693) $ 80,618
Balance at the end (in shares) at Dec. 31, 2021 20,776,217